Skip to main content
Top

Current Oncology Reports

Issue 10/2023

Content (13 Articles)

Open Access Radiotherapy

Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity

Jesús Chamorro Pérez, Alfonso Cortes Salgado, Belén Pérez-Mies, Jose Antonio Domínguez Rullán, Odile Ajuria-Illarramendi, Eva María Guerra Alia, Juan José Serrano Domingo

Open Access Correction

Correction to: Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity

Jesús Chamorro Pérez, Alfonso Cortes Salgado, Belén Perez‑Mies, Jose Antonio Domínguez Rullán, Odile Ajuria‑Illarramendi, Eva María Guerra Alia, Juan José Serrano Domingo

Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines

Michał Gawlik, Jakub Michal Zimodro, Aleksandra Gąsecka, Krzysztof J. Filipiak, Sebastian Szmit

Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment

Nikolaos Andreatos, Patrick W. McGarrah, Mohamad Bassam Sonbol, Jason S. Starr, Jaume Capdevila, Halfdan Sorbye, Thorvardur R. Halfdanarson

Open Access Obesity

Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients

Alberto Dalla Volta, Irene Caramella, Pierluigi Di Mauro, Marco Bergamini, Deborah Cosentini, Francesca Valcamonico, Carlo Cappelli, Marta Laganà, Nunzia Di Meo, Davide Farina, Rebecca Pedersini, Gherardo Mazziotti, Alfredo Berruti

Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors

Fernanda Hayashida Yoshimoto, Cecilia Félix Penido Mendes de Sousa, Gustavo Nader Marta, Samir Abdallah Hanna

Open Access NSCLC Lung Cancer

Cellular Therapy in NSCLC: Between Myth and Reality

Martina Imbimbo, Laureline Wetterwald, Alex Friedlaender, Kaushal Parikh, Alfredo Addeo

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine